Stockhead TV
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on HeraMED.
RELATED STOCKHEAD STORIES
Health & Biotech
Successful clinical study for HeraBEAT device showcases its telehealth application
Health & Biotech
HeraMED breaks into US healthcare market with eCare21 partnership
Health & Biotech
Here’s what the telehealth industry wants from ScoMo to maintain momentum
Health & Biotech
HeraMED opens up new medtech markets with clinical study milestone
Health & Biotech
Here are the top adopters of telehealth — and the biggest ASX winners
Health & Biotech
How tech is changing healthcare, and where professional ASX investors are looking
Health & Biotech
HeraMED announces new research collaboration with Mayo Clinic
Health & Biotech
US FDA approval is on the agenda for these 5 ASX small caps
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
New investors back HeraMed’s latest raise to the tune of $2.3m
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
HeraMED gets set for Aussie clinical trials with new deal
Health & Biotech
HeraMED ramps up Australian strategy with new distribution deal
News
V-Con Recap: Here are the most important things we learned about the future of telehealth
Stockhead TV
Stockhead V-Con: The Future of TeleHealth
Health & Biotech
